EXPRESSION OF THE LOW-AFFINITY NERVE GROWTH-FACTOR RECEPTOR ENHANCES BETA-AMYLOID PEPTIDE TOXICITY

被引:112
作者
RABIZADEH, S
BITLER, CM
BUTCHER, LL
BREDESEN, DE
机构
[1] UNIV CALIF LOS ANGELES,DEPT PSYCHOL,LOS ANGELES,CA 90024
[2] UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024
[3] UNIV CALIF LOS ANGELES,BRAIN RES INST,DEPT NEUROL,LOS ANGELES,CA 90024
[4] STANFORD RES INST,MENLO PK,CA 94025
关键词
P75(NGFR); TRKA; NEURODEGENERATIVE DISEASE;
D O I
10.1073/pnas.91.22.10703
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The low-affinity nerve growth factor receptor (NGFR) p75(NGFR) induces apoptosis in the absence of nerve growth factor (NGF) binding but enhances neural survival when bound by NGF. Basal forebrain cholinergic neurons express the highest levels of p75(NGFR) in the adult human brain and are preferentially involved in Alzheimer disease, raising the question of whether there may be a functional relationship between the expression of p75(NGFR) and basal forebrain cholinergic neuronal degeneration in Alzheimer disease. The expression of p75(NGFR) by wild-type and mutant PC12 cells potentiated cell death induced by beta-amyloid peptide. NGF binding to p75(NGFR) inhibited the toxicity of beta-amyloid peptide, whereas NGF binding to TrkA, the high-affinity NGFR, enhanced it. These results suggest a possible link between beta-amyloid peptide toxicity and preferential degeneration of cells expressing p75(NGFR).
引用
收藏
页码:10703 / 10706
页数:4
相关论文
共 26 条
[1]   AMYLOID DEPOSITION IN THE NUCLEUS BASALIS OF MEYNERT COMPLEX - A TOPOGRAPHIC MARKER FOR DEGENERATING CELL CLUSTERS IN ALZHEIMERS-DISEASE [J].
ARENDT, T ;
TAUBERT, G ;
BIGL, V ;
ARENDT, A .
ACTA NEUROPATHOLOGICA, 1988, 75 (03) :226-232
[2]   LESIONS OF THE NUCLEUS ANSAE-PEDUNCULARIS IN NEUROPSYCHIATRIC DISEASE [J].
AVERBACK, P .
ARCHIVES OF NEUROLOGY, 1981, 38 (04) :230-235
[3]   VITAMIN-E PROTECTS NERVE-CELLS FROM AMYLOID BETA-PROTEIN TOXICITY [J].
BEHL, C ;
DAVIS, J ;
COLE, GM ;
SCHUBERT, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 186 (02) :944-950
[4]   CHOLINERGIC PROJECTIONS FROM THE BASAL FOREBRAIN TO FRONTAL, PARIETAL, TEMPORAL, OCCIPITAL, AND CINGULATE CORTICES - A COMBINED FLUORESCENT TRACER AND ACETYLCHOLINESTERASE ANALYSIS [J].
BIGL, V ;
WOOLF, NJ ;
BUTCHER, LL .
BRAIN RESEARCH BULLETIN, 1982, 8 (06) :727-749
[5]  
BIGL V, 1990, BRAIN CHOLINERGIC SY, P364
[6]   BIOCHEMICAL-STUDIES OF NERVE-CELLS AND ENERGY-METABOLISM IN ALZHEIMERS-DISEASE [J].
BOWEN, DM ;
DAVISON, AN .
BRITISH MEDICAL BULLETIN, 1986, 42 (01) :75-80
[7]   DISTRIBUTION OF CEREBRAL DEGENERATION IN ALZHEIMERS-DISEASE - CLINICOPATHOLOGICAL STUDY [J].
BRUN, A ;
GUSTAFSON, L .
ARCHIV FUR PSYCHIATRIE UND NERVENKRANKHEITEN, 1976, 223 (01) :15-33
[8]   REASSESSING THE CHOLINERGIC BASAL FOREBRAIN - NOMENCLATURE SCHEMATA AND CONCEPTS [J].
BUTCHER, LL ;
SEMBA, K .
TRENDS IN NEUROSCIENCES, 1989, 12 (12) :483-485
[9]  
Cummings J L, 1987, Alzheimer Dis Assoc Disord, V1, P128, DOI 10.1097/00002093-198701030-00003
[10]  
DAVIES P, 1976, LANCET, V2, P1403